Filing Details
- Accession Number:
- 0001019695-18-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-11 11:23:42
- Reporting Period:
- 2018-05-10
- Accepted Time:
- 2018-05-11 11:23:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1019695 | Arqule Inc | ARQL | Pharmaceutical Preparations (2834) | 043221586 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1436861 | Paolo Pucci | C/O Arqule, Inc. 1 Wall Street, 6Th Floor Burlington MA 01803 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-10 | 1,300 | $2.64 | 405,494 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the weighted average price as the shares were purchased in multiple transactions. The per share transaction price ranged from $2.62 to $2.65. The Reporting Person hereby undertakes to provide, upon request, by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
